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Herein, the interaction of CeO2 NPs with HSA was explored by fluorescence, CD, UVevis and molecular
docking studies. Afterwards, the antioxidant activity of CeO2 NPs against H2O2-induced oxidative stress
in BM-MSCs were explored by MTT, ROS and apoptosis assays. Antibacterial assay was also done on two
Gram-positive and Gram-negative bacterial strains. Fluorescence study showed that the interaction of
CeO2 NPs with HSA occurs through static quenching and hydrophilic interactions are involved in the
spontaneous complex formation. The theoretical study also revealed that the distribution of hydrophilic
residues of HSA is dominant in the binding site. CD and UVevis techniques also revealed that the
ellipticity changes and Tm of HSA, respectively did not alter significantly in the presence of CeO2 NPs.
Cellular assays depicted that CeO2 NPs did not induce cytotoxicity against BM-MSC up to 50 mg/ml for
24 h and pretreatment of cells with CeO2 NPs can reduce the cell mortality, ROS production and apoptosis
in BM-MSC exposed to oxidative stress. The antibacterial assay revealed that CeO2 NPs have a significant
antibacterial effect against all studied bacterial strains. This study may provide useful details about the
biomedical applications of CeO2 NPs.
© 2019 Elsevier B.V. All rights reserved.), rasti@liau.ac.ir (B. Rasti),1. Introduction
Since the appearance of nanotechnology, nanoparticles (NPs)
have been wildly implemented as potential agents in biotechno-
logical [1] and medical sciences [2]. NPs encircle a wide number of
different materials which supply a high-yielding base for creativity,
inventiveness, investigation and buildout. Although, macroscopic
materials normally stand in need of remarkable bioactivity due to
low biodistribution, and quickly and fully soluble particles usually
S.Z. Khoshgozaran Roudbaneh et al. / Journal of Molecular Liquids 296 (2019) 1118392perform exclusively via chemical reactions, nano-based materials
bring into play their function on biological systems through several
mechanisms. Furthermore, NPs are considered to be extremely
reactive chemically due to their large surface/volume ratio, as well
as potential release systems for biologically vital compounds. For
example, NPs may be used as an antioxidant agents as well as drug
carriers for the delivery of antioxidant enzymes to reduce reactive
oxygen species (ROS) [3]. As reported by Gaucher et al., certain NPs
may preserve cells by decreasing ROS [3]. Also, it has been revealed
that NPs may show potential antibacterial effects against a wide
range of bacterial strains [4,5]. Therefore, NPs may form a thera-
peutic standpoint which may facilitate the development of systems
performing through a combination of physical and chemical kinds
of interaction. The potency of NPs as drugs is associated with
gradually gathering at the area of operation at healing levels,
anyhow, challenges such as quick renal clearance, lack of biocom-
patibility and degradation responses or non-targeted drug delivery
make necessary NP delivery qualifying assemblies. Albumin is
known as a natural carried protein with several ligand binding
positions, cellular receptors, and a long bioavailability [6]. Utiliza-
tion of these features stimulates albumin as a potential agent for
bioavailability extension and selective intracellular delivery of NPs
attached by ligand-mediated interactions.
Mesenchymal stem cells (MSCs) therapy can be used against a
wide range of disorders [7,8]; however, high levels of ROS derived
from the microenvironment of injury site may induce mortality of
MSCs [9]. Therefore, NP technology and MSCs therapy can be
combined to mitigate the oxidative stress-induced mortality of
MSCs [9].
In another view, the spread of antibiotic resistant bacteria has
resulted in exploring brand new potential antibacterial candidates
[10].
Cerium oxide (CeO2) NPs have been reported to work as excel-
lent candidate in biological applications [11], nanomedicine [12],
antibacterial agents [13], biomedical applications [13], and bio-
sensors [14].
For example, Hirst et al. (2009) [15] and Wason et al. (2013) [16]
reported that CeO2 NPs show anti-inflammatory and anticancer
properties, respectively. Recently Bellio et al. (2018) [17] revealed
that as CeO2 NPs can be used as a novel antibiotic adjuvant.
Furthermore, Eriksson et al. (2018) [18] demonstrated that CeO2
NPs possess antioxidant activities and can be employed as a com-
plement agent for MRI contrast.
Although, the antioxidant and antibacterial properties of the
NPs have been extensively studied, the simultaneous study of their
binding properties to proteins and the calculation of their binding
and thermodynamic parameters along with their antimicrobial and
antioxidant properties can be of interest. Indeed, when considering
the pharmacological properties of NPs, it is important to evaluate
all aspects including their interaction with carrier proteins and
their medicinal properties such as antioxidant and antibacterial
features.
Therefore, we tried to explore the human serum albumin (HSA)
binding properties of CeO2 NPs as well as structural changes of
protein after interaction with CeO2 NPs by biophysical and theo-
retical approaches. Afterwards, protective impacts of CeO2 NPs on
oxidative stress-induced apoptosis in human bone marrow (BM)-
MSCs will be investigated by cellular assays. Finally, the antibac-
terial effects of CeO2 NPs against four pathogenic bacteria,
including E. coli ATCC 25922, Klebsiella Pneumoniae ATCC 13883,
Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus
ATCC 25923 were explored.2. Materials and methods
2.1. Materials
HSA was obtained from Sigma-Aldrich Company (Sigma-
Aldrich, St Louis, MO, USA). CeO2 NPs (purity: 99.97%, APS:
10e30 nm, SSA: 30e50m2/g, color: light yellow, bulk density:
~0.8e1.1 g/cm3, true density: 7.132 g/cm3) was purchased from US
Research Nanomaterials, Inc. (Houston, TX 77084, USA).2.2. Methods
2.2.1. Protein and NP preparation
HSA solution was prepared in10 mM phosphate buffer, pH 7.4
and NP solution was dissolved in double-distilled water. NP solu-
tion was then sonicated for 20min at 50 C employing a sonicator
probe (Misonix- S3000, USA). HSA concentration was calculated
using the Beer-Lambert equation with an extinction coefficient of
35700M1 cm1 in a UVevis spectrophotometer. Also, the con-
centration of CeO2 was calculated based on the following equation
½CeO2 NP ¼ ðW=r V vÞ (1)
where,W, r, V, and v are weight, density, the volume of a single NP,
and final volume of colloidal solution, respectively.2.2.2. XRD analysis of NPs
The XRD pattern of CeO2 NPs was investigated by an X-ray
diffractometer (PW1730, voltage: 40 kV, current: 30mA; Philips,
Netherlands) at a 2q in the range of 10e80.2.2.3. Intrinsic fluorescence study
Fluorescence spectroscopy was carried out to determine the
mechanism of quenching, binding parameters and thermodynamic
parameters of Hb after interaction with CeO2 NPs.
HSA solution with a concentration of 2 mM was titrated with
different concentrations of CeO2 NPs (2e20 mM) and fluorescence
spectra (lex: 280 with slit width of 5 nm; lex: 310e450 nm with
slit width of 10 nm) were read by Cary Eclipse fluorescence spec-
trofluorometer (Varian, Australia) at 298 K, 310 K, and 315 K. All
spectra were corrected against fluorescence intensities of NP so-
lution, buffer solution, and inner filter effects.
Stern-Volmer equation (2) was used to determine the kind of
quenching mechanism based on the following equation (2) [19]:
F0 = F ¼KSV ½NP þ1¼ kq t0½NP (2)
where, F, Fo, KSV [NP], kq, and t0 represent the fluorescence in-
tensity of HSA incubated with NP, the fluorescence intensity of HSA,
Stern-Volmer constant, collision-quenching rate constant, and an
average fluorescent lifetime of the macromolecules without NP
(108 s).
Moreover, binding constants [number of binding sites (n) and
binding constant (Kb)] were calculated based on the modified Hill
equation (3) [19]:
Log ½F0 F = F ¼n log ½NP þlogKb (3)
Furthermore, thermodynamic parameters [enthalpy changes
(DH) and entropy changes (DS)] were estimated using the van’t
Hoff equation (4) [19]:
LnKb ¼  DH=RTþ DS=RT (4)
Finally, the free Gibbs energy (DG) was calculated employing
Gibbs-Helmholtz equation (5) [19]:
Fig. 1. XRD pattern of the CeO2 NPs.
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2.2.4. Simulation methods
Three spherical nanoclusters with diameters of 1, 2 and 3 nm
and a cubic nanocluster with a diameter of 1.5 nm were developed
by repeating CeO2 unit cell [20]. The 3D X-ray crystal conformation
of HSA was obtained from the Protein Data Bank (PDB ID: 1AO6).
Hex 6.3 (http://hexserver.loria.fr/) as the docking program was
utilized to study CeO2 nanoclusters-HSA interactions [21].
2.2.5. Circular dichroism study
Far UV-Circular dichroism (CD) [(190e260) nm, HSA concen-
tration (200 mg/ml)] was performed by a spectropolarimeter
(model 215, Aviv, Lakewood, NJ, USA) with a scan rate of 2 nm/s to
determine the secondary structural changes of HSA titrated with
different concentrations of CeO2 NPs (1,10 50 mg/ml). The ellipticity
changes of buffer and NP solution was subtracted from the protein
signal.
2.2.6. UVevis study
UVevis spectroscopy study was performed to determine the
melting temperature (Tm) of HSA in the forms of free as well as
complex states using a absorbance spectrometer (Varian, Australia).
HSA with a concentration of 500 mg/ml was incubated with 50 mg/
ml of CeO2 NPs for 2min. Afterwards, the absorbance changes of
protein samples were read versus a temperature range of 40e90 C
with a scan rate of 1 C/min. The absorbance of HSA samples was
corrected against NP and buffer intensities.
2.2.7. Cell culture
BM-MSCs were obtained from Royan Institute of Tehran, Iran
which had been extracted under Ethical approval from Royan
Institute Ethics Committee and characterized data for MSCmarkers
and cell culture were provided in Pourgholaminejad et al. (2016)
study [22]. Therefore, the cell culture was done based on a previous
report [22]. After removing non-adherent cells and reaching
confluence, cell treatment was carried out.
2.2.8. Cell treatments and MTT assay
To explore the protective impact of CeO2 NPs, cells were pre-
treated with various concentrations of CeO2 NPs (0.1e50 mg/mL) for
12 h, followed by addition of 200 mM H2O2 for 12 h at 37 C. Cells
that did not receive specific treatment were considered as the
control group. The viability percent of BM-MSCs was analyzed us-
ing the MTT assay based on the previous report [20].
2.2.9. ROS levels
The production of intracellular ROS was examined based on the
protocol of DCFDA/H2DCFDA - Cellular ROS Assay Kit (ab113851).
Briefly, following appropriate treatments, the cells were collected,
stained with 30 mM of DCFH-DA for 30min. Afterwards, the fluo-
rescence intensity of the probe was assessed by flow cytometry
(FACSCalibur; BD Biosciences, San Jose, CA, USA).
2.2.10. Apoptosis detection by flow cytometry
Annexin V-FITC assay protocol for Annexin V-FITC Apoptosis
Staining/Detection Kit (ab14085) was used to quantify the
apoptosis and necrosis. After treatment, cells were collected,
resuspended in 500 ml of 1 Annexin V binding buffer, stained with
5 ml of Annexin V-FITC and 5 ml Propidium Iodide (PI), and incu-
bated at room temperature for 10min. Cells were then assessed by
flow cytometry (FACSCalibur; BD Biosciences, San Jose, CA, USA).2.2.11. Agar well diffusion method
In order to evaluation of the antibacterial activity of CeO2 NPs,
agar well diffusion method was used. Briefly, the four pathogenic
bacteria including E. coli ATCC 25922, Klebsiella Pneumoniae ATCC
13883, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus
aureus ATCC 25923 were cultured in LB broth until 0.5 McFarland.
Subsequently, each bacteriumwas coated over the agar plate using
sterile cotton swabs. A 6mm diameter well was punched on Muller
Hinton Agar, and various concentrations of CeO2 NPs (200, 100, 50,
25 mg/mL) was added to each well. After 24 h incubation at 37 C,
the diameter of inhibitory zones measured in mm. Moreover, a
concentration of 6 mg/ml of ciprofloxacin was used as a positive
control.
2.2.12. Determination of MIC and MBC
In this study, the antibacterial activity of the CeO2 NPs was also
investigated by determination of minimum inhibitory concentra-
tion (MIC) and minimum bactericidal concentration (MBC). Briefly,
the various concentrations of CeO2 NPs including 200, 100, 50, 25,
12.5, 6.25, 3.125 and 1.56 mg/mL was prepared and added into the
wells. Subsequently, bacterial suspension with 0.5 McFarland was
added to each well and incubated at 37

C for 24 h. The MIC is
defined as the lowest concentration that inhibits microbial growth,
whereas the MBC was defined as the lowest concentration of
antimicrobial agent that can kill 100% of bacteria.
2.2.13. Statistical analyses
Data extracted from control and incubated samples with CeO2
NPs were statistically analyzed using one-way ANOVA followed by




The morphology and vibrational mode of CeO2 NPs were fully
explored by TEM and FTIR, respectively in our previous paper [20].
Briefly, it was shown that spherical CeO2 NPs have a diameter of
about 30 nm and vibration peaks around 738 cm1, indicating the
presence of pure CeO2 NPs with a narrow size distribution [20].
Also, to more verify the crystalline structure of CeO2 NPs, the XRD
pattern was determined. As, shown in Fig. 1, the XRD patterns
Fig. 2. The fluorescence quenching spectra of free HSA or incubated with varying concentrations of CeO2 NPs. (A) 298 K, (B) 310 K, and (C) 315 K.
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77.31 with different intensities of 1713.84, 509.54, 1139.43, 999.85,
179.93, 184.53, 366.99, and 250.86 counts, respectively. This data is
in good agreement with the standard data reported for XRD pattern
of CeO2 NPs.
3.2. Fluorescence quenching of HSA
Fluorescence quenching study can be used to determine the
complex specification such as binding constants and thermody-
namic parameters [23,24]. Fig. 2 displays the fluorescence
quenching of HSA titrated with increasing concentrations of CeO2
NPs at 298 K Fig. 2A, 310 K Fig. 2B, and 315 K Fig. 2C. This data may
represent that aromatic residue may relocate in the protein struc-
ture during adsorption of Hb onto the CeO2 NP surface [25].
KSV and kq can be calculated to determine the quenching
mechanism between NPs and biomolecules. Based on equation (1),
the KSV and kq values for the interaction of CeO2 NP with HSA
deriving from Fig. 3A were calculated and tabulated in Table 1. As
summarized in Table 1, the KSV and kq values at 298 K, 310 K, and
315 K are 2.25 105M1, 8.56 104M1, 3.46 104M1 and
2.25 1013M1 s1, 8.56 1012M1 s1, 3.46 1012M1 s1,
respectively. Because KSV values reduce as the temperature of the
system increases and kq is much larger than 1010M1 s1, it may be
suggested that the quenching mechanism between CeO2 NP and
HSA occurs through static quenching [26,27].Also, the F0 and F presented in Fig. 2 can be used to calculate the
binding parameters such as n and Kb based on the Hill equation.
Fig. 3B shows the modified Hill plot for the interaction of CeO2 NP
with HSA. The calculated binding parameters are summarized in
Table 2.
A larger Kb and n values at 298 K in comparison with higher
temperatures reveals the higher level of association between NPs
and HSA at a lower temperature. Indeed, these values reduce as the
temperature increases, revealing the slight conformational changes
induced by temperature, which may displace the interacting resi-
dues located at the binding site of HSA with NPs.
The sign of thermodynamic parameters deduced form van’t Hoff
equation can determine the binding affinity, kind of binding forces
and the spontaneity of a reaction.
Fig. 3C shows the van’t Hoff plot and the estimated thermody-
namic parameters are tabulated in Table 3. The values of DSo and
DHo are determined to be 646.56 kJ/mol and 594.10 kJ/mol at
room temperature. The negative values of DHo and DSo may
designate the formation of van der Waals forces and hydrogen
bonding in the adoption position of HSA onto the NP surface
[28,29].
3.3. Molecular docking study
The type of interaction between CeO2 NPs and HSA, which was
explored by fluorescence investigation, was further verified by
Fig. 3. (A) SterneVolmer plots, (B) Modified Hill plot, and (C) van’t Hoff plot for the interaction of HSA with CeO2 NPs.
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regarding interaction residues and preferable binding sites. To
compare the effect of size and morphology of CeO2 nanoclusters on
their affinities to bind HSA, at first three spherical clusters with
different sizes and a cubic nanocluster with a size of 1.5 nm were
developed by the repetition of CeO2 unit cell [20]. Afterwards, the
cluster/HSA interaction was done by Hex 6.3 program for all
designed cluster models. The interaction analysis for 3 spherical
nanoclusters with dimensions of 1 nm (Fig. 4A), 2 nm (Fig. 4B) and
3 nm (Fig. 4C) and a cubic nanocluster with the size of 1.5 nm
(Fig. 4D) gives binding energies of 277.70 E-value, 444.89 E-
value, 67.65 E-value, and 831.41 E-value, respectively (Table 4).
Stand on the highest binding energy, cubic nanocluster with the
size of 1.5 after interaction with HSA shows preferable binding in
comparison with other nanoclusters.
Fig. 5 shows the residues surrounding the spherical CeO2
nanocluster with dimensions of 1 nm (Fig. 5A), 2 nm (Fig. 5B) and a
cubic nanocluster with the size of 1.5 nm (Fig. 5C) within 4 Å
explored by using graphical tools. Furthermore, all residues in theTable 1
KSV and kq values for the interaction of CeO2 NPs with HSA.
T (K) KSV (M1) kq (L mol1s1) R2
298 2.25 105 2.25 1013 0.97
310 8.56 104 8.56 1012 0.91
315 3.46 104 3.46 1012 0.91binding sites are summarized in Table 4. It is evident from Table 4,
the binding energy of cubic nanocluster is remarkably more
negative than other nanoclusters, and this nanocluster interacts
with Ser-435.B, Glu-400.B, Gly-399.B, Glu-294.A, Cys-289.A, Glu-
188.A, Asp-187.A, Glu-292.A, Lys-444.B, His-440.A, Lys-439.B, Lys-
436.A, Ser-435.residues. Therefore, this data may assign that
hydrogen bonding and van der Waals interactions are playing a
main role in the complex formation between CeO2 NPs and HSA,
and this is in agreement with the thermodynamics data derived
from fluorescence spectroscopy experiment.3.4. Circular dichroism study
The circular dichroism (CD) spectroscopy can be employed to
explore the structural alterations of free biomolecules or incubated
with ligands [19,30] based on the ellipticity changes. Indeed, the CD
technique is helpful to determine the probable impact of the
interaction action on the secondary structure of the biomolecules.
HSA demonstrates in the UV region at 208 and 222 nm twominima,Table 2
Kb and n values for the interaction of CeO2 NPs with HSA.
T (K) n LogKb (M1) R2
298 1.78 9.04 0.96
310 1.41 7.05 0.90
315 0.47 2.09 0.99
Table 3
Thermodynamic parameters of the HSA/CeO2 NPs complex.
T (K) DG (kJ/mol) DH (kJ/mol) TDS (kJ/mol)
298 52.45 646.56 594.10
310 40.61 605.95
315 12.67 633.88
Also, the negative value of DGo proposed that the absorption of HSA molecules onto
the CeO2.
NP surface occurs spontaneously.
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[31]. CD study executed in the presence of increasing concentra-
tions of NPs showed that the binding of CeO2 NPs to HSA did not
lead to a significant reduction in ellipticity (Fig. 6). The CD data
were formulated based on themean residue ellipticity (MRE) in deg
cm2 dmol1, as reported by the following equation (6) [19].
MRE¼Observed CD ðmdegÞ= Cp nl 10 (6)
where Cp shows the molar concentrations of the biomolecule, n
represent the total of building block and l is the path length.
The a-helix contents of free and complex HSA were estimated
from mean residue ellipticity changes at 222 nm using the
following equation (7) [19]:Fig. 4. The molecular binding interaction between HSA and three spherical nanoclusters wit
of 1.5 nm.a  helix%¼ MRE222  2340=30300 100 (7)
Therefore, it was estimated that the reduction of a-helical
content is about 0.7%, 1.2% and 1.7% for HSA in the presence of 1 mg/
ml, 10 mg/ml and 50 mg/ml CeO2 NPs, respectively.3.5. Melting temperature measurement
The UVevis spectroscopy can be utilized to calculate the Tm
value of biomolecules in terms of absorbance changes versus
temperature [32]. The UVevis technique is serviceable to find out
the expected influence of the reaction approaches on the structural
destabilization of the proteins. Plotting first derivative of absor-
bance versus temperature also can be used to calculate the Tm
values. As shown in Fig. 7, the absorbance of free HSA and HSA
complex at 280 nm increases as temperature goes up. Fig. 7 (inset)
also represent that both free HSA and interacted one show Tmvalue
of around 70 C nm, determining the preservation of HSA confor-
mation even after interaction with CeO2 NPs.
Initially, the influences of CeO2 NPs with different concentra-
tions of 0.1 mg/ml, 1 mg/ml, 10 mg/ml, 20 mg/ml and 50 mg/ml on BM-
MSCs viability for 24 h was examined using the MTT assay. As
shown in Fig. 8, treatment of cells with different concentrations of
CeO2 NPs for 24 h influenced little effect on cell viability inh different size of (A) 1 nm, (B) 2 nm, (C) 3 nm, and (D) A cubic nanocluster with the size
Table 4






Spherical 1 277.70 Arg-114.B, Leu-112.B,Asn-109.B,Thr-442.B,Pro 421.B
Spherical 2 444.89 Glu-294.B, Ala-443.B,Glu-442.B,Pro-441.B, Gln-397.A, Glu-393.A
Spherical 3 67.65 _
Cubic 1.5 831.41 Ser-435.B, Glu-400.B, Gly-399.B, Glu-294.A, Cys-289.A, Glu-188.A, Asp-187.A, Glu-292.A, Lys-444.B, His-440.A, Lys-439.B,
Lys-436.A, Ser-435.A
S.Z. Khoshgozaran Roudbaneh et al. / Journal of Molecular Liquids 296 (2019) 111839 7comparisonwith the control group. This data determined that CeO2
NPs did not trigger cytotoxic effects on BM-MSCs up to 50 mg/ml for
24 h. Therefore, CeO2 NPs with a concentration of 50 mg/ml wasFig. 5. Analysis of HSA residues contributed in the binding site with spherical CeO2 nanoclu
1.5 nm within 4 Å at two rotational angles..used to study the antioxidant effect of CeO2 NPs on H2O2-induced
oxidative stress in BM-MSCs.ster with dimensions of (A) 1 nm, (B) 2 nm, and (C) A cubic nanocluster with the size of
Fig. 6. CD bands of free HSA and HSA/CeO2 NPs complex with various concentrations
of NPs at room temperature.
Fig. 8. MTT assay of BM-MSCs in the presence of varying concentrations of CeO2 NPs
(0.1e50 mg/ml) for 24 h.
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BM-MSCs
H2O2 has been shown to trigger cell mortality at different con-
centrations and time-intervals [20,21]. In this study, following
treatment of cells with a single concentration of H2O2 (200 mM) for
12 h or CeO2 NPs with different concentrations of 1 mg/ml, 10 mg/ml,
20 mg/ml and 50 mg/ml followed by H2O2 for 12 h, we performed
MTT assay. As shown in Fig. 9, BM-MSCs incubated with H2O2 had
profoundly lower cell viability (***P< 0.001, relative to control
group) in comparison with BM-MSCs protected by CeO2 NPs with
different concentrations of 10 mg/ml (#P< 0.05, relative to H2O2-
treated group), 20 mg/ml (#P< 0.05, relative to H2O2-treated group)
and 50 mg/ml (##P< 0.01, relative to H2O2-treated group).Fig. 7. Thermal profile of free HSA and HSA/CeO2 NPs (50 mg/3.7. CeO2 NPs remarkably mitigates H2O2-induced ROS production
of BM-MSCs
H2O2 treatment can result in the intracellular ROS elevation of
different cells. To further examine the influences of the CeO2 NPs
against ROS production in H2O2-triggered BM-MSCs, we carried out
the DCFH-DA staining test. As displayed in Fig. 10A, the DCFH in-
tensity was around 103 unit in the negative control group, whereas
we observed that H2O2 incubation increased the level of ROS pro-
duction in BM-MSCs from 103 to 544 unit (Fig. 10B). However,
pretreatment with the CeO2 NPs (50 mg/ml) for 12 h led to a
remarkable reduction in the level of ROS production (Fig. 10C).
These data represented that H2O2 treatment significantly enhanced
the level of ROS production (***P< 0.001, relative to control group),
nevertheless, CeO2 NPswith a concentration of 50 mg/ml potentiallyml). The inset shows the first derivative of O.D. versus T.
Fig. 9. Influence of CeO2 NPs on BM-MSCs viability in H2O2-triggered oxidative stress.
***P < 0.001 versus control, #P< 0.05 and ##P< 0.01 versus H2O2 treated cells.
Fig. 10. Protective effect of CeO2 NPs on intracellular ROS production in BM-MSCs exposed to
NPs (50 mg/mL) for 12 h. The ROS productionwas measured by the DCFH assay. (A) Control ce
and (D) Statistical analysis of ROS assay. ***P < 0.001 versus control and ##P< 0.01 versus
S.Z. Khoshgozaran Roudbaneh et al. / Journal of Molecular Liquids 296 (2019) 111839 9declined the intracellular ROS generation in BM-MSCs treated with
H2O2 (##P< 0.01, relative to H2O2-treated group) (Fig. 10D).
3.8. CeO2 NPs outstandingly reduces H2O2-induced apoptosis of
BM-MSCs
To further explore the protective impact of CeO2 NPs against
apoptosis in H2O2-induced BM-MSCs, flow cytometry assay was
performed. After treatment of BM-MSCs with a single concentra-
tion of H2O2 (200 mM) for 12 h or CeO2 NPs with a concentration of
50 mg/ml followed by addition of H2O2 for 12 h, BM-MSCs were
stained with Annexin V-FITC/PI. The proportion of early apoptotic
cells, late apoptotic cells, and necrotic cells were 4.88%, 4.37%, 5.38%
(Fig. 11A), 4.46%, 32.42%, 29.61% (Fig. 11B), 3.66%, 9.31%, 6.92%
(Fig. 11C), in control cells, H2O2-treated cells and H2O2-treated cells
pre-incubated with CeO2 NPs (50 mg/ml), respectively. As shown in
Fig. 11D, the late apoptosis (***P< 0.001, relative to control group)
and necrosis (***P< 0.001, relative to control group) were signifi-
cantly enhanced following incubationwith 200 mMH2O2. However,
pre-treatment of cells with CeO2 NPs results in a reduction of late
apoptosis (###P< 0.001, relative to H2O2-treated cells) and necrosis
(###P< 0.001, relative to H2O2-treated cells).H2O2. Cells were exposed to H2O2 (200 mM, for 12 h) after pretreatment with the CeO2
lls, (B) H2O2-treated cells, (C) Pretreated cells by CeO2 NPs followed by addition of H2O2,
H2O2 treated cells.
Fig. 11. Antiapoptotic effect of CeO2 NPs on apoptosis induction in BM-MSCs exposed to H2O2. Cells were exposed to H2O2 (200 mM, for 12 h) after pretreatment with the CeO2 NPs
(50 mg/mL) for 12 h. The quantification of apoptosis was calculated by the Annexin-V/PI assay. (A) Control cells, (B) H2O2-treated cells, (C) Pretreated cells by CeO2 NPs followed by
addition of H2O2, and (D) Statistical analysis of apoptosis assay. ***P < 0.001 versus control and ###P< 0.001 versus H2O2 treated cells.
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Antibacterial activity of CeO2 NPs is depicted in Fig. 12. The re-
sults show that the CeO2 NPs had antibacterial activity against
selected bacteria. Table 5 shows the inhibition zone diameter
(millimeter) of CeO2 NPs against S. aureus, E. coli, P. aeruginosa, and
K. pneumoniae strains. As we can observe, inhibition zone of CeO2
NPs was depending on their concentrations and the large inhibition
zone was related to 200 mg/mL concentration for all bacteria.
Among them, at the same concentration (200 mg/mL), the largest
inhibition zone was related to E. coli and S. aureus (37± 0.5mm). In
addition, at the concentration of 6 mg/ml of ciprofloxacin,
P. aeruginosa and S. aureus had no inhibition zone, whereas otherbacteria showed inhibition zone in the same concentration3.10. MIC and MBC methods
In this study, the antibacterial activity of CeO2 NPs was also
determined using other approaches, MIC and MBC methods. The
CeO2 NPs were shown to be more effective against E. coli in com-
parison with other strains. The MIC and MBC values (mg/mL) of
CeO2 NPs against studied bacteria are shown in Table 6. Based on
the results, the CeO2 NPs showed a very profound antibacterial
activity against both Gram-positive and Gram-negative bacteria at
very low concentrations.
Fig. 12. Inhibition zone induced by CeO2 NPs against S. aureus, K. pneumoniae, E. coli, and P. aeruginosa strains.
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In this study, we showed by fluorescence spectroscopy that
some environmental changes around aromatic residues may occur
upon the interaction of HSA with CeO2 NP. Also, quenching type
was deduced to be based on the static quenching. Binding constant
such as n and Kb were calculated, and it was concluded that tem-
peraturemight influence the binding affinity of protein toward NPs.
Thermodynamic parameters were also estimated, and it was
demonstrated that hydrophilic interaction are involved in the for-
mation of CeO2 NP/HSA complex.
Theoretical studies also represented that CeO2 nanocluster with
different morphologies and diameters can interact with different
residues on the HSA structure. However, the distribution of hy-
drophilic residues was more dominant in the binding site, which is
in agreement with fluorescence data.
Song et al. (2011) [33] showed that fullerene NPs with the
diameter of around 50e110 nm interact with HSA through staticquenching, and some environmental changes occur around aro-
matic residues. Furthermore, Huang et al. (2015) [34] displayed that
graphene-quantum dots (QDs) with the size of 1.2 nm result in the
formation of a static complex with HSA and establish some hy-
drophilic interactions with HSA residues. However, it was revealed
that the reaction forces upon the interaction of cadmium telluride-
QDs with the dimension of around 5 nm and HSA are electrostatic
interaction [35].
Regarding the CD and UVevisible sturdy, we demonstrated that
CeO2 NPs did not perturb the secondary structure of HSA and Tm of
protein incubated with CeO2 NPs was almost similar to free HSA.
Treuel et al. (2010) [36] also demonstrated that citrate-func-
tionalized gold (Au) and silver (Ag) NPs provide much stronger
interactions and structural changes with bovine serum albumin
(BSA) than polymeric or polymer-coated counterparts.
Ansari et al. (2018) [37] also depicted that bare and surface
functionalized titanium oxide NPs did not alter the structure of
HSA.
Table 5
Average inhibition zone of CeO2 NPs.
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induce some slight changes in the HSA and hemoglobin structure
and may be used as potential antibacterial agents in medicine.
However, Ambika et al. (2015) [39] exhibited that bio-fabricated
zinc oxide (ZnO) NPs may result in secondary structural changes
of HSA. Ali et al. (2015) [40] also depicted that interaction of HSA
with Ag NP coated with polyvinylthiol cause secondary structural
alternations of protein. Moreover, Navvenraj et al. (2018) [41] re-
ported that (nickel, copper, Zn) selenide NPs show different affinity
and interaction with HSA and induce some structural changes.
Shcharbin et al. (2018) [42] suggested that functional moieties and
the core of capped Au NPsmay influence their interactionwith HSA.
Therefore, it should be noted different parameters affect the kind of
interaction between NPs and proteins and corresponding structural
changes of biomolecules.
Regarding cellular (antioxidant) assays, it was indicated that
CeO2 NPs did not induce significant cytotoxicity against BM-MSCs
up to 50 mg/ml for 12 h. Also, CeO2 NPs can mitigate the cell mor-
tality, ROS production and apoptosis in H2O2-induced oxidative
stress in BM-MSCs. Rather et al. (2018) [43] also revealed that CeO2
NPs capped with polycaprolactone -gelatin fibers can be utilized as
promising antioxidant agents for wound healing implementations.
Moreover, Xue et al. (2018) [44] showed that pegylated CeO2 NPs
could serve as an excellent antioxidant candidate. Furthermore,
Patel et al. (2018) [45] displayed that CeO2 NPs can cross the cell
membrane of human monocytic leukemia cells and trigger signif-
icant antioxidant activity.
Abuid et al. (2019) [46] also depicted that CeO2 NPs can be used
as coating particles for antioxidant preservation of encapsulated
Beta cells. Filippi et al. (2019) [47] showed that morphology of CeO2
NPs can play a key role in their antioxidant activity and proposed
that CeO2 nanorods provide higher antioxidant activity than CeO2
NPs. It has also been revealed that antioxidant properties of CeO2
NPs can be considered as a potential point in hemostasis [48], skinTable 6
MIC and MBC of CeO2 NPs against pathogenic bacteria. The data were reported as
mean± SD of the three independent experiments.
Bacteria MIC (mg/mL) MBC (mg/mL)
S. aureus 25± 0.0 50± 14.43
E. coli 6.25± 3.6 12.5± 0.0
P. aeruginosa 12.5± 0.0 25± 14.43
K. pneumoniae 12.5± 3.6 25± 0.0tissue engineering [49], regulation of oxidative markers [50], pho-
toprotection [51], bone regeneration [52], and diabetic wound
healing [53]. It may be indicated that the mechanism of antioxidant
properties of NPs like CeO2 is due to the oxidase [54] and super-
oxide dismutase-like activity of NPs [55]. Indeed, it has beenwidely
shown that NPs can be considered as nonozymes in the biological
systems, where they can serve as antioxidant agents to catalyze the
conversion of free radicals into non-toxic agents [56e59].
The results of this study also showed that the CeO2 NPs had
significant antibacterial activity against both Gram-positive and
Gram-negative bacteria, with more pronounced antibacterial ac-
tivity against Gram-negative strains (E. coli).
There are limited studies about the evaluation of the antibac-
terial activity of CeO2 NPs. According to Zeyons et al. [60], Pelletier
et al. [61], and Kuang et al. [62], CeO2 NPs have antibacterial activity
against E. coli. Moreover, Gopinath et al., reported that the anti-
bacterial activity of CeO2 NPs in Gram-positive bacteria is due to
teichoic acid in peptidoglycan [63].
The MIC of CeO2 NPs was observed at 25 mg/mL for S. aureus,
6.25 mg/mL for E. coli, 12.5 mg/mL for both of P. aeruginosa and
K. pneumoniae. The higher antibacterial activity of CeO2 NPs against
E. coli comparing to other bacterial strains may be due to different
structure and thickness of cell wall. Moreover, based on the well
diffusion results, it can be concluded that the antimicrobial activity
of CeO2 NPs is concentration dependent, whereas, at the concen-
tration of 6 mg/ml of ciprofloxacin, P. aeruginosa and S. aureus had
no inhibition zone, whereas other bacteria showed inhibition zone
in the same concentration. It appears that P. aeruginosa and
S. aureus are intrinsically resistant to this concentration of cipro-
floxacin. One of the reasons for more antimicrobial activity of CeO2
NPs against Gram-negative bacteria is due to the variation in the
thickness of the peptidoglycan in these bacterial strains [64].
Another antibacterial mechanism of CeO2 NPs is the binding of
CeO2 NPs to the surface of the cell membrane that changes the
permeability and respiration of bacteria [60]. Also, in oxi-reduction
process, the reduction of Ce4þ to Ce3þ occurs, resulting in oxidative
stress on lipids and proteins in the plasma membrane of cells [56].
Also, some studies reported that the CeO2 NPs attack to electron
flow and bacterial respiration and cause impairment of cellular
respiration [60e64].
Besides CeO2 NP, the antibacterial activity of other NPs such as
ZnONPs [65], titanium oxide NPs [66], nickel oxide NPs [67], copper
oxide NPs [68], and Ag NPs [69] have been reported recently.
It has been showed that NPs generate significant level of ROS as
the major cause of antibacterial activity [70]. Such reactive species
cause destruction of cellular components such as lipids, DNA and
proteins as a result of entry to bacterial cells [71]. The another
antibacterial mechanism of NPs has been shown to be due to the
release of ions which provides a dramatic effect on inhibition of
active transport, amino acid metabolism and enzyme disruption
[72,73]. The cell energy also decreases in cells following treatment
to NPs due to decline in the ATP levels [74,75]. Moreover, NPs with
different physicochemical properties can disrupt the membrane
integrity causing membrane dysfunction [76].
Also, metal NPs usually carry positive charges which result in an
electromagnetic attraction between bacteria and the surface of
metal NPs [77]. This attraction leads to oxidation and antibacterial
effects of NPs [78].
According to the results, it can be concluded the CeO2 NPs have
the greater antibacterial activity against Gram-negative bacteria in
comparisonwith Gram-positive strains, and it can be used as a drug
candidate in future.
Therefore, it may be indicated that CeO2 NPs can hold a great
promise in regulating oxidative stress in injured tissues as well as
potency materials for the development of antibacterial agents.
However, it should be emphasized that some reports regarding the
S.Z. Khoshgozaran Roudbaneh et al. / Journal of Molecular Liquids 296 (2019) 111839 13toxicity of CeO2 NPs have been reported [79,80]. Hence, more
detailed research should be carried out to explore the mechanism
of cytotoxicity, antioxidant activity and antibacterial effects of CeO2
NPs.
5. Conclusion
In this study, the interaction HSA and CeO2 NPs was explored by
several spectroscopic techniques as well as molecular docking
investigation. It was depicted that HSA interacts with CeO2 NPs to
form a stable static HSA-CeO2 NPs complex. Also, fluorescence data
suggested that the interaction of CeO2 NPs with HSA is sponta-
neous, and the dominant involving forces are hydrogen bonding
and van der Waals interactions. Furthermore, it was determined
that secondary structure and Tm of HSA did not change when
incubated with CeO2 NPs. Additionally; the docking study revealed
that nanoclusters with different sizes and morphologies could bind
to HSAwith different affinities. In the cellular assays, we found that
CeO2 NPs can mitigate the oxidative stress induced by H2O2 in BM-
MSCs and following ROS production and apoptosis. Finally, it was
shown that CeO2 NPs could be used as potential antibacterial
candidate, especially against gram-negative pathogens.
The binding responses of CeO2 NPs with biomolecules are
important features in understanding the toxicity and bioavailability
of CeO2 NPs in biological systems. In the future, we can also explore
the effect of several parameters such as the dimension, functional
groups and chemical composition of NPs, promoting the exami-
nation of the impact of different factors on the binding character-
istics of NP-protein complexes as well as antioxidant and
antibacterial properties of NPs. This study may provide useful data
regarding the safe and potential implementation of NPs in biolog-
ical systems.
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